Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Behav Res Ther. 2017 Jun 3;97:1–13. doi: 10.1016/j.brat.2017.06.001

Table 1.

Demographics and Clinical Characteristic of Randomized Participants (N = 108)

Characteristic CBGT
(n= 36)
MBSR
(n= 36)
WL
(n= 36)
Males, No. (%) 16 (44.4) 16 (44.4) 16 (44.4)
Age, mean (SD), years 34.1 (8.0) 29.9 (7.6) 34.1 (7.8)
Education, mean (SD), years 17.4 (3.3) 16.2 (1.7) 16.5 (2.9)
Ethnicity, No. (%)
    Caucasian 18 (50.0) 14 (38.9) 15 (41.7)
    Asian 15 (41.7) 13 (36.1) 14 (38.9)
    Latino 2 (5.5) 7 (19.4) 1 (2.8)
    African American 0 1 (2.8) 0
    American Indian / Alaskan Native 0 0 1 (2.8)
    More than One Race 1 (2.8) 1 (2.8) 5 (13.9)
Yearly income, No. (%)
    <10k 3 (8.3) 3 (8.3) 1 (2.8)
    10–25k 3 (8.3) 2 (5.6) 4 (11.1)
    25–50k 5 (13.9) 5 (13.9) 5 (13.9)
    50–75k 6 (16.7) 5 (13.9) 3 (8.3)
    75–100k 4 (11.1) 3 (8.3) 4 (11.1)
    >100k 9 (25.0) 9 (25.0) 10 (27.8)
    Not reported 6 (16.7) 9 (25.0) 9 (25.0)
Marital status, No. (%)
    Single, never married 20 (55.6) 23 (63.9) 18 (50.0)
    Married 12 (33.3) 8 (23.8) 16 (44.4)
    Divorced, separated, widowed 1 (2.8) 0 0
    Living with partner 3 (8.3) 5 (13.9) 1 (2.8)
    Not reported 0 0 1 (2.8)
Current Axis I Comorbidity, No. (%)
    Generalized anxiety disorder 13 (36.1) 10 (27.8) 8 (22.2)
    Specific phobia 4 (11.1) 10 (27.8) 5 (13.9)
    Panic disorder 8 (22.2) 4 (11.1) 2 (5.6)
    Major depressive disorder 1 (2.8) 2 (5.6) 1 (2.8)
    Dysthymic disorder 2 (5.6) 2 (5.6) 3 (8.3)
    Obsessive compulsive disorder 0 1 (2.8) 0
Past Axis I Comorbidity, No. (%)
    Generalized anxiety disorder 1 (2.8) 0 1 (2.8)
    Panic disorder 3 (8.3) 3 (8.3) 1 (2.8)
    Major depressive disorder 13 (36.1) 17 (47.2) 12 (33.3)
    Dysthymic disorder 1 (2.8) 1 (2.8) 2 (5.6)
    Obsessive compulsive disorder 1 (2.8) 1 (2.8) 1 (2.8)
    Post-traumatic stress disorder 0 0 0
    Substance abuse disorder 3 (8.3) 3 (8.3) 2 (5.6)
    Eating disorder 2 (5.6) 1 (2.8) 2 (5.6)
Past non-CBT Psychotherapy, No. (%) 20 (55.6) 18 (50.0) 23 (63.9)
Past Pharmacotherapy, No. (%) 15 (41.7) 15 (41.7) 13 (36.1)
Age at symptom onset, mean (SD), years 9.0 ± 5.1 9.4 ± 5.1 8.3 ± 5.0
Years since symptom onset, mean (SD), years 25.1 ± 1.3 20.5 ± 9.1 25.8 ± 8.3

Note: All comparisons (between-group t-test or χ2 tests) are non-significant, p > .05. CBGT = cognitive behavioral group therapy, MBSR = mindfulness-based stress reduction, WL = waitlist group, SD = standard deviation, No. = number, k = thousand dollars. Previously published in Goldin et al., 2016; published with permission from American Psychological Association.